Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.
about
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsChemical constituents of ambient particulate air pollution and biomarkers of inflammation, coagulation and homocysteine in healthy adults: a prospective panel studyThe -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.Associations of Serum 25-Hydroxyvitamin D With Hemostatic and Inflammatory Biomarkers in the Multi-Ethnic Study of Atherosclerosis.PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).Hesperetin and its sulfate and glucuronide metabolites inhibit TNF-α induced human aortic endothelial cell migration and decrease plasminogen activator inhibitor-1 (PAI-1) levels.Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.Role of Vascular Endothelial Cells in Disseminated Intravascular Coagulation Induced by Seawater Immersion in a Rat Trauma Model.The urea decomposition product cyanate promotes endothelial dysfunction.Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.Epigenetic determinants of cardiovascular gene expression: vascular endothelium.Adipokine Profiling in Adult Women With Central Obesity and Hypertension.
P2860
Q27000495-1ABAD12A-E5A2-421A-A914-6B7FA6A6F59AQ28395077-B72565B2-6131-40E0-ACF4-77607A715BAEQ35151527-C17A30FC-E7E0-484A-B6BC-F67A01B72F33Q35764595-574E3584-FC14-4AFD-8F41-3326BEB403B6Q35931125-3D212363-06CA-4F3D-BA8B-1F5A9D061733Q36965300-44937A03-63C9-42E5-B34D-4897109C6FAEQ37668960-30E1A0FB-92F0-44F5-85B8-CC5FF04F09F5Q38092174-4A5FF4A2-BFAD-47C4-9E58-185BE00BBF96Q38828868-36DC4DF0-1B78-487F-8B0F-826EDCA8E298Q39722375-AC98B038-C2E8-4B93-802A-016F012A66D4Q40287159-84C544A7-974A-4EDB-8EEF-E3B16A370A57Q41857889-D2F81F69-FB37-40F3-B995-4BE41DF0629CQ42025075-ABA7F3FB-A485-48B4-A220-23BCBDDFBD38Q46442151-B6967BFA-B0A2-4680-BC9F-FDEAFDEEF7ADQ51661768-9918DDA4-710B-4FA1-B240-E5752EE28B98Q55548906-7CD8CFE1-9941-4AB3-AF32-3D56A4DA7C24
P2860
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effects of altered plasminogen ...... ion on cardiovascular disease.
@en
type
label
Effects of altered plasminogen ...... ion on cardiovascular disease.
@en
prefLabel
Effects of altered plasminogen ...... ion on cardiovascular disease.
@en
P2860
P1433
P1476
Effects of altered plasminogen ...... ion on cardiovascular disease.
@en
P2093
Victoria A Ploplis
P2860
P304
P356
10.2174/138945011797635803
P577
2011-11-01T00:00:00Z